[Results of synkavit treatment of psoriasis vulgaris].
D000933:Antifibrinolytic Agents; D006801:Humans; D011565:Psoriasis / Q000628:therapy*; D012176:Retinoids; D014812:Vitamin K / Q000627:therapeutic use* / Q000031:analogs & derivatives
D000933:Antifibrinolytic Agents; D012176:Retinoids; D014812:Vitamin K; C023885:menadiol
PSORIASIS/therapy; VITAMIN K/therapeutic use
Ergebnisse der Behandlung von Psoriasis vulgaris mit Synkavit.